MaaT Pharma Overview

  • Founded
  • 2014

Founded
  • Status
  • Public

  • Employees
  • 33

Employees
  • Stock Symbol
  • MAAT

Stock Symbol
  • Share Price
  • $10.53

  • (As of Friday Closing)

MaaT Pharma General Information

Description

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PAR
Primary Office
  • 70 Avenue Tony Garnier
  • 69007 Lyon
  • France
+33 04 00 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MaaT Pharma Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.53 $10.61 $10.03 - $16.66 $105M 9.9M 510.79 -$4.37

MaaT Pharma Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 137,385 137,385
Revenue 1,149 1,149 0 0
EBITDA (10,132) (10,132) (5,804) (6,411)
Net Income (10,663) (10,663) (6,043) (6,542)
Total Assets 55,954 55,954 29,859 9,152
Total Debt 6,574 6,574 7,473 11,723
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MaaT Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MaaT Pharma‘s full profile, request access.

Request a free trial

MaaT Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore MaaT Pharma‘s full profile, request access.

Request a free trial

MaaT Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapi
Drug Discovery
Lyon, France
33 As of 2021
000.00
0000 0000-00-00
00000000 000.00

00000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ali
0000 000000000
Woburn, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000
Cambridge, MA
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MaaT Pharma Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axial Therapeutics Venture Capital-Backed Woburn, MA 00 00000 00000000000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000 Formerly VC-backed Somerville, MA 000 00000 00000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000000 Venture Capital-Backed Paris, France 00 00000 0000000000 0 00000
You’re viewing 5 of 16 competitors. Get the full list »

MaaT Pharma Patents

MaaT Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3895716-A4 Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients Ceased 17-Apr-2020 000000000
EP-3895716-A1 Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients Ceased 17-Apr-2020 000000000 0
EP-3597202-A1 Fecal microbiota composition, for use in reducing treatment-induced inflammation Ceased 20-Jul-2018 000000000 0
US-20210299188-A1 Fecal microbiota composition for use in reducing treatment-induced inflammation Pending 20-Jul-2018 000000000
JP-2021530527-A Fecal microflora composition for use in reducing treatment-induced inflammation Granted 20-Jul-2018 A61K35/38
To view MaaT Pharma’s complete patent history, request access »

MaaT Pharma Executive Team (12)

Name Title Board Seat Contact Info
Herve Affagard Co-Founder, Chief Executive Officer & Board Member
Siân Crouzet Chief Operating Officer & Chief Financial Officer
Carole Schwintner Chief Technology Officer
Savita Bernal Chief Business Officer
Mohamad Mohty MD Co-Founder & Medical Haematology-Oncology Advisor
You’re viewing 5 of 12 executive team members. Get the full list »

MaaT Pharma Board Members (15)

Name Representing Role Since
Claude Bertrand MaaT Pharma Board Member 000 0000
Dorothée Burkel Self Board Member 000 0000
Herve Affagard MaaT Pharma Co-Founder, Chief Executive Officer & Board Member 000 0000
Isabelle de Cremoux Seventure Partners Board Member 000 0000
Jean Volatier Self Board Member 000 0000
You’re viewing 5 of 15 board members. Get the full list »

MaaT Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial